Mission Biocapital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
A venture studio embedded within Alloy Therapeutics that partners with academics, entrepreneurs, pharma companies, and VCs to create and develop early-stage drug discovery companies.
BiotechDeep TechWaltham, US
Errik B. Anderson(Executive Officer, Director)inPiotr Bobrowicz(Executive Officer, Director)Jay Rosanelli(Executive Officer)
BoardAnthony Sun(Director)Alaa Halawa(Director)Ulrik Nielsen(Director)in
Board seatUlrik B. Nielsen· per SEC Form D · $40M raise · filed Apr 2026
Co-investors82VS8VCJIC Venture Growth InvestmentsMC Healthcare Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.